United States · FDA National Drug Code directory
CITALOPRAM HYDROBROMIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71610-092_d05f4e71-95f3-4f22-8b01-b21e5c19e0f2
- Product NDC
- 71610-092
- Form
- TABLET
- Composition / generic term
- CITALOPRAM
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20171110
- Source listing expiry
- 20261231
Source-listed ingredients
- CITALOPRAM HYDROBROMIDE — 20 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 15 TABLET in 1 BOTTLE (71610-092-15) · 71610-092-15
- 30 TABLET in 1 BOTTLE (71610-092-30) · 71610-092-30
- 45 TABLET in 1 BOTTLE (71610-092-45) · 71610-092-45
- 90 TABLET in 1 BOTTLE (71610-092-60) · 71610-092-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →